|
1
|
Davies L and Welch HG: Increasing
incidence of thyroid cancer in the United States, 1973–2002. JAMA.
295:2164–2167. 2006.
|
|
2
|
Hay ID, Thompson GB, Grant CS, et al:
Papillary thyroid carcinoma managed at the Mayo Clinic during six
decades (1940–1999): temporal trends in initial therapy and
long-term outcome in 2444 consecutively treated patients. World J
Surg. 26:879–885. 2002.PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
White NM, Fatoohi E, Metias M, Jung K,
Stephan C and Yousef GM: Metastamirs: a stepping stone towards
improved cancer management. Nat Rev Clin Onco. 8:75–84. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pallante P, Visone R, Croce CM and Fusco
A: Deregulation of microRNA expression in follicular-cell-derived
human thyroid carcinomas. Endocr Relat Cancer. 17:F91–F104. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wilson C: Cancer: MicroRNA expression
provides clues about the aggressiveness of papillary thyroid
carcinoma. Nat Rev Endocrinol. 6:4162010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vasko V, Espinosa AV, Scouten W, et al:
Gene expression and functional evidence of
epithelial-to-mesenchymal transition in papillary thyroid carcinoma
invasion. Proc Natl Acad Sci USA. 104:2803–2808. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang Z, Fan Y, Deng Z, Wu B and Zheng Q:
Amyloid precursor protein as a potential marker of malignancy and
prognosis in papillary thyroid carcinoma. Oncol Lett. 3:1227–1230.
2012.PubMed/NCBI
|
|
9
|
Stinson S, Lackner MR, Adai AT, et al:
miR-221/222 targeting of trichorhinophalangeal 1 (TRPS1) promotes
epithelial-to-mesenchymal transition in breast cancer. Sci Signal.
4:20022582011.PubMed/NCBI
|
|
10
|
Yip L, Kelly L, Shuai Y, et al: MicroRNA
signature distinguishes the degree of aggressiveness of papillary
thyroid carcinoma. Ann Surg Oncol. 18:2035–2041. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zheng C, Yinghao S and Li J: MiR-221
expression affects invasion potential of human prostate carcinoma
cell lines by targeting DVL2. Med Oncol. 29:815–822. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang C, Zhang J, Hao J, et al: High level
of miR-221/222 confers increased cell invasion and poor prognosis
in glioma. J Transl Med. 10:1192012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geraldo MV, Yamashita AS and Kimura ET:
MicroRNA miR-146b-5p regulates signal transduction of TGF-β by
repressing SMAD4 in thyroid cancer. Oncogene. 31:1910–1922.
2012.PubMed/NCBI
|
|
14
|
Chou CK, Chen RF, Chou FF, et al: miR-146b
is highly expressed in adult papillary thyroid carcinomas with high
risk features including extrathyroidal invasion and the
BRAFV600E mutation. Thyroid. 20:489–494. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chou CK, Yang KD, Chou FF, et al:
Prognostic implications of miR-146b expression and its functional
role in papillary thyroid carcinoma. J Clin Endocrinol Metab.
98:E196–E205. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo CJ, Pan Q, Li DG, Sun H and Liu BW:
miR-15b and miR-16 are implicated in activation of the rat hepatic
stellate cell: An essential role for apoptosis. J Hepatol.
50:766–778. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gao Y, Wang C, Shan Z, et al: MiRNA
expression in a human papillary thyroid carcinoma cell line varies
with invasiveness. Endocr J. 57:81–86. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Anania MC, Sensi M, Radaelli E, et al:
TIMP3 regulates migration, invasion and in vivo tumorigenicity of
thyroid tumor cells. Oncogene. 30:3011–3023. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hao HX, Xie Y, Zhang Y, et al: ZNRF3
promotes Wnt receptor turnover in an R-spondin-sensitive manner.
Nature. 485:195–200. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sastre-Perona A and Santisteban P: Role of
the Wnt pathway in thyroid cancer. Front Endocrinol (Lausanne).
3:312012.PubMed/NCBI
|
|
21
|
Ponzo MG, Lesurf R, Petkiewicz S, et al:
Met induces mammary tumors with diverse histologies and is
associated with poor outcome and human basal breast cancer. Proc
Natl Acad Sci USA. 106:12903–12908. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Previdi S, Maroni P, Matteucci E, Broggini
M, Bendinelli P and Desiderio MA: Interaction between human-breast
cancer metastasis and bone microenvironment through activated
hepatocyte growth factor/Met and beta-catenin/Wnt pathways. Eur J
Cancer. 46:1679–1691. 2010. View Article : Google Scholar
|
|
23
|
Strillacci A, Valerii MC, Sansone P, et
al: Loss of miR-101 expression promotes Wnt/β-catenin signaling
pathway activation and malignancy in colon cancer cells. J Pathol.
229:379–389. 2013.PubMed/NCBI
|
|
24
|
Bandapalli OR, Dihlmann S, Helwa R, et al:
Transcriptional activation of the β-catenin gene at the invasion
front of colorectal liver metastases. J Pathol. 218:370–379.
2009.
|
|
25
|
Cho SW, Lee EJ, Kim H, et al: Dickkopf-1
inhibits thyroid cancer cell survival and migration through
regulation of β-catenin/E-cadherin signaling. Mol Cell Endocrinol.
366:90–98. 2013.PubMed/NCBI
|
|
26
|
Kalluri R and Weinberg RA: The basics of
epithelial - mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Viana LS, Affonso RJ Jr, Silva SR, et
al: Relationship between the expression of the extracellular matrix
genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological
parameters of tumor progression and colorectal cancer
dissemination. Oncology. 84:81–91. 2013.
|
|
28
|
Alexi X, Berditchevski F and Odintsova E:
The effect of cell-ECM adhesion on signalling via the ErbB family
of growth factor receptors. Biochem Soc Trans. 39:568–573. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Foubert P and Varner JA: Integrins in
tumor angiogenesis and lymphangiogenesis. Methods Mol Biol.
757:471–486. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Guo F and Zhu G: Involvement of
host cell integrin α2 in Cryptosporidium parvum infection.
Infect Immun. 80:1753–1758. 2012.
|
|
31
|
Chen J, Liu NN, Li JQ, et al: Association
between ITGA2 C807T polymorphism and gastric cancer risk. World J
Gastroenterol. 17:2860–2866. 2011.PubMed/NCBI
|
